{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:34:24Z","timestamp":1791408864501,"version":"4.3.3"},"reference-count":71,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T00:00:00Z","timestamp":1560988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Citrin Foundation","award":["RG17001"],"award-info":[{"award-number":["RG17001"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.ymgme.2019.06.004","type":"journal-article","created":{"date-parts":[[2019,6,15]],"date-time":"2019-06-15T10:35:44Z","timestamp":1560594944000},"page":"175-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Current treatment for citrin deficiency during NICCD and adaptation\/compensation stages: Strategy to prevent CTLN2"],"prefix":"10.1016","volume":"127","author":[{"given":"Yoshiyuki","family":"Okano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Ohura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayano","family":"Inui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2019.06.004_bb0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BFb0034071","article-title":"Hereditary disorders of the urea cycle in man: biochemical and molecular approaches","volume":"108","author":"Saheki","year":"1987","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0010","series-title":"Calcium: The Molecular Basis of Calcium Action in Biology and Medicine","first-page":"565","article-title":"Type II citrullinemia (citrin deficiency): A mysterious disease caused by a defect of calcium-binding mitochondrial carrier protein","author":"Kobayashi","year":"2000"},{"key":"10.1016\/j.ymgme.2019.06.004_bb0015","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/9667","article-title":"The gene mutated in adult-onset type II citrullinaemia encodes a putative mitochondrial carrier protein","volume":"22","author":"Kobayashi","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0020","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1067\/mpd.2001.113264","article-title":"Infantile cholestatic jaundice associated with adult-onset type II citrullinemia","volume":"138","author":"Tazawa","year":"2001","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0025","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1067\/mpd.2001.113361","article-title":"Possible clinical and histological manifestations of adult-onset type II citrullinemia in early infancy","volume":"138","author":"Tomomasa","year":"2001","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0030","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s004390000448","article-title":"Neonatal presentation of adult-onset type II citrullinemia","volume":"108","author":"Ohura","year":"2001","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0035","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S1096-7192(03)00140-9","article-title":"Screening of nine SLC25A13 mutations: their frequency in patients with citrin deficiency and high carrier rates in Asian populations","volume":"80","author":"Kobayashi","year":"2003","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0040","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s10038-005-0262-8","article-title":"Frequency and distribution in East Asia of 12 mutations identified in the SLC25A13 gene of Japanese patients with citrin deficiency","volume":"50","author":"Lu","year":"2005","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0045","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s10038-008-0282-2","article-title":"Identification of 13 novel mutations including a retrotransposal insertion in SLC25A13 gene and frequency of 30 mutations found in patients with citrin deficiency","volume":"53","author":"Tabata","year":"2008","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0050","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ymgme.2008.10.007","article-title":"Citrin deficiency, a perplexing global disorder","volume":"96","author":"Dimmock","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0055","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00431-002-1045-2","article-title":"Neonatal intrahepatic cholestasis caused by citrin deficiency: severe hepatic dysfunction in an infant requiring liver transplantation","volume":"161","author":"Tamamori","year":"2002","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0060","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1203\/01.PDR.0000139713.64264.BC","article-title":"Effects of citrin deficiency in the perinatal period: feasibility of newborn mass screening for citrin deficiency","volume":"56","author":"Tamamori","year":"2004","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0065","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10545-007-0506-1","article-title":"Clinical pictures of 75 patients with neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD)","volume":"30","author":"Ohura","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0070","doi-asserted-by":"crossref","first-page":"E86","DOI":"10.1111\/j.1399-3046.2009.01172.x","article-title":"Liver transplantation for an infant with neonatal intrahepatic cholestasis caused by citrin deficiency using heterozygote living donor","volume":"14","author":"Shigeta","year":"2010","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0075","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s10545-008-0752-x","article-title":"Reduced carbohydrate intake in citrin-deficient subjects","volume":"31","author":"Saheki","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0080","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ymgme.2011.12.024","article-title":"Simple and rapid genetic testing for citrin deficiency by screening 11 prevalent mutations in SLC25A13","volume":"105","author":"Kikuchi","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0085","first-page":"1024","article-title":"A search for the primary abnormality in adult-onset type II citrullinemia","volume":"53","author":"Kobayashi","year":"1993","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0090","doi-asserted-by":"crossref","first-page":"844","DOI":"10.5692\/clinicalneurol.50.844","article-title":"Therapeutic approaches for patients with adult-onset type II citrullinemia (CTLN2): effectiveness of treatment with low-carbohydrate diet and sodium pyruvate","volume":"50","author":"Yazaki","year":"2010","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.ymgme.2019.06.004_bb0095","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ymgmr.2013.12.002","article-title":"Medium-chain triglyceride supplementation under a low-carbohydrate formula is a promising therapy for adult-onset type II citrullinemia","volume":"1","author":"Hayasaka","year":"2014","journal-title":"Mol. Genet. Metab. Reports"},{"key":"10.1016\/j.ymgme.2019.06.004_bb0100","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1038\/s41598-019-39627-y","article-title":"Pivotal role of inter-organ aspartate metabolism for treatment of mitochondrial aspartate-glutamate carrier 2 (citrin) deficiency, based on the mouse model","volume":"9","author":"Saheki","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0105","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1093\/emboj\/20.18.5060","article-title":"Citrin and aralar1 are Ca (2+)-stimulated aspartate\/glutamate transporters in mitochondria","volume":"20","author":"Palmieri","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0110","doi-asserted-by":"crossref","first-page":"23327","DOI":"10.1074\/jbc.273.36.23327","article-title":"Molecular cloning of Aralar, a new member of the mitochondrial carrier superfamily that binds calcium and is present in human muscle and brain","volume":"273","author":"del Arco","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0115","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s100380200046","article-title":"Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idiopathic neonatal hepatitis (NICCD)","volume":"47","author":"Saheki","year":"2002","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0120","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.bbadis.2014.12.011","article-title":"Steatogenesis in adult-onset type II citrullinemia is associated with down-regulation of PPAR\u03b1","volume":"1852","author":"Komatsu","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2019.06.004_bb0125","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1570-0232(02)00077-6","article-title":"Newborn mass screening and selective screening using electrospray tandem mass spectrometry in Japan","volume":"776","author":"Shigematsu","year":"2002","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0130","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/jhg.2016.131","article-title":"Biochemical and molecular characteristics of citrin deficiency in Korean children","volume":"62","author":"Oh","year":"2017","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0135","doi-asserted-by":"crossref","first-page":"7331","DOI":"10.3748\/wjg.v21.i23.7331","article-title":"Citrin deficiency presenting as acute liver failure in an eight-month-old infant","volume":"21","author":"Zhang","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"Suppl. 3","key":"10.1016\/j.ymgme.2019.06.004_bb0140","doi-asserted-by":"crossref","first-page":"S489","DOI":"10.1007\/s10545-010-9248-6","article-title":"Neonatal intrahepatic cholestasis associated with citrin deficiency (NICCD): a case series of 11 Malaysian patients","volume":"33","author":"Chew","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0145","first-page":"33","article-title":"Genotypic and phenotypic features of citrin deficiency: five-year experience in a Chinese pediatric center","volume":"28","author":"Song","year":"2011","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0150","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12887-018-1383-5","article-title":"Risk factors associated with mortality in neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD) and clinical implications","volume":"19","author":"Abuduxikuer","year":"2019","journal-title":"BMC Pediatr."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0155","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/1471-230X-12-141","article-title":"Neonatal intrahepatic cholestasis caused by citrin deficiency: prevalence and SLC25A13 mutations among Thai infants","volume":"12","author":"Treepongkaruna","year":"2012","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0160","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1872-034X.2009.00594.x","article-title":"Histological findings in the livers of patients with neonatal intrahepatic cholestasis caused by citrin deficiency","volume":"40","author":"Kimura","year":"2010","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0165","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00431-003-1171-5","article-title":"A novel inborn error of metabolism detected by elevated methionine and\/or galactose in newborn screening: Neonatal intrahepatic cholestasis caused by citrin deficiency","volume":"162","author":"Ohura","year":"2003","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0170","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1023\/A:1015198103395","article-title":"Type II citrullinemia (citrin deficiency) in a neonate with hypergalactosemia detected by mass screening","volume":"25","author":"Naito","year":"2002","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0175","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ymgme.2006.09.009","article-title":"Novel diagnostic approach to citrin deficiency: analysis of citrin protein in lymphocytes","volume":"90","author":"Tokuhara","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0180","series-title":"Citrin deficiency working group, Efficacy of MCT-milk in NICCD, The AASPP-International Symposium on Citrin Deficiency in Matsumoto","author":"Takeda","year":"2011"},{"key":"10.1016\/j.ymgme.2019.06.004_bb0185","first-page":"37","article-title":"K, Treatment with lactose (galactose)-restricted and medium-chain triglyceride-supplemented formula for neonatal intrahepatic cholestasis caused by citrin deficiency","volume":"2","author":"Hayasaka","year":"2012","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0190","first-page":"57","article-title":"Neonatal intrahepatic cholestasis caused by citrin deficiency: Efficacy of therapeutic formulas and update of clinical outcomes","volume":"26","author":"Song","year":"2010","journal-title":"Jpn. J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0195","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0022-3476(85)80282-1","article-title":"Neonatal cholestasis","volume":"106","author":"Balistreri","year":"1985","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0200","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2141.2004.04973.x","article-title":"Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials","volume":"126","author":"Stanworth","year":"2004","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0205","first-page":"219","article-title":"Sodium pyruvate treatment for persistent NICCD","volume":"33","author":"Tanaka","year":"2017","journal-title":"Jpn. J. Inher. Metab. Dis"},{"key":"10.1016\/j.ymgme.2019.06.004_bb0210","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3177\/jnsv.57.239","article-title":"The characteristics of food intake in patients with type II citrullinemia","volume":"57","author":"Nakamura","year":"2011","journal-title":"J. Nutr. Sci. Vitaminol."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0215","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s11136-010-9834-y","article-title":"Reliability and validity of the PedsQL\u2122 multidimensional fatigue scale in Japan","volume":"20","author":"Kobayashi","year":"2011","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0220","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ymgme.2013.01.020","article-title":"Fatigue and quality of life in citrin deficiency during adaptation and compensation stage","volume":"109","author":"Okano","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0225","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/MPG.0b013e3181d67fbf","article-title":"Nonalcoholic fatty liver disease in 2 siblings with adult-onset type II citrullinemia","volume":"50","author":"Lee","year":"2010","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0230","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jhep.2008.05.016","article-title":"Citrin deficiency as a cause of chronic liver disorder mimicking non-alcoholic fatty liver disease","volume":"49","author":"Komatsu","year":"2008","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0235","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jhep.2005.08.024","article-title":"Adult onset type II citrullinemia as a cause of non-alcoholic steatohepatitis","volume":"44","author":"Takagi","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0240","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/hepr.12559","article-title":"Chronic hepatitis without hepatic steatosis caused by citrin deficiency in a child","volume":"46","author":"Inui","year":"2016","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0245","series-title":"GeneReviews\u2122 [Internet]. Seattle (WA)","article-title":"Citrin deficiency","author":"Kobayashi","year":"2005"},{"key":"10.1016\/j.ymgme.2019.06.004_bb0250","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/jimd.12051","article-title":"Growth impairment in individuals with citrin deficiency","volume":"42","author":"Numakura","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2019.06.004_bb0255","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/j.ymgme.2010.02.014","article-title":"Citrin deficiency and current treatment concepts","volume":"100","author":"Saheki","year":"2010","journal-title":"Mol. Genet. Metab."},{"issue":"Suppl. 2","key":"10.1016\/j.ymgme.2019.06.004_bb0260","doi-asserted-by":"crossref","first-page":"S343","DOI":"10.1007\/s10545-008-0914-x","article-title":"Treatment of a citrin-deficient patient at the early stage of adult-onset type II citrullinaemia with arginine and sodium pyruvate","volume":"31","author":"Mutoh","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0265","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1386-6346(02)00331-5","article-title":"Effectiveness of carbohydrate-restricted diet and arginine granules therapy for adult-onset type II citrullinemia: a case report of siblings showing homozygous SLC25A13 mutation with and without the disease","volume":"26","author":"Imamura","year":"2003","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0270","doi-asserted-by":"crossref","first-page":"W109","DOI":"10.7326\/0003-4819-141-7-200410050-00028-w1","article-title":"Chronic pancreatitis associated with adult-onset type II citrullinemia: clinical and pathologic findings","volume":"141","author":"Ikeda","year":"2004","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0275","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/01.mcg.0000225683.29841.9c","article-title":"Primary liver carcinoma exhibiting dual hepatocellular-biliary epithelial differentiations associated with citrin deficiency: a case report","volume":"42","author":"Soeda","year":"2008","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0280","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/pcn.12253","article-title":"Case of adult-onset type II citrullinemia treated as schizophrenia for a long time","volume":"69","author":"Kyo","year":"2015","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0285","doi-asserted-by":"crossref","first-page":"e530","DOI":"10.1542\/peds.2014-4172","article-title":"An adolescent case of citrin deficiency with severe anorexia mimicking anorexia nervosa","volume":"136","author":"Takeuchi","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2019.06.004_bb0290","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ymgme.2004.06.018","article-title":"Clinical heterogeneity of neonatal intrahepatic cholestasis caused by citrin deficiency: case reports from 16 patients","volume":"83","author":"Tazawa","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0295","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/hep.510250519","article-title":"Pancreatic secretory trypsin inhibitor as a diagnostic marker for adult-onset type II citrullinemia","volume":"25","author":"Kobayashi","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.ymgme.2019.06.004_bb0300","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s10545-018-0176-1","article-title":"Medium-chain triglycerides supplement therapy with a low-carbohydrate formula can supply energy and enhance ammonia detoxification in the hepatocytes of patients with adult-onset type II citrullinemia","volume":"41","author":"Hayasaka","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0305","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ymgme.2011.08.015","article-title":"Metabolomic analysis reveals hepatic metabolite perturbations in citrin\/mitochondrial glycerol-3-phosphate dehydrogenase double-knockout mice, amodel of human citrin deficiency","volume":"104","author":"Saheki","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0310","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ymgme.2012.07.021","article-title":"Effects of supplementation on food intake, body weight and hepatic metabolites in the citrin\/mitochondrial glycerol-3-phosphate dehydrogenase double-knockout mouse model of human citrin deficiency","volume":"107","author":"Saheki","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0315","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.bbadis.2015.04.023","article-title":"Mechanism for increased hepatic glycerol synthesis in the citrin\/mitochondrial glycerol-3-phosphate dehydrogenase doubleknockout mouse: urine glycerol and glycerol 3-phosphate as potential diagnostic markers of human citrin deficiency","volume":"1852","author":"Moriyama","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2019.06.004_bb0320","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ymgme.2017.02.004","article-title":"Oral aversion to dietary sugar, ethanol and glycerol correlates with alterations in specific hepatic metabolites in a mouse model of human citrin deficiency","volume":"120","author":"Saheki","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0325","doi-asserted-by":"crossref","first-page":"e773","DOI":"10.1542\/peds.2006-1950","article-title":"Citrin deficiency: a novel cause of failure to thrive that responds to a high-protein, low-carbohydrate diet","volume":"119","author":"Dimmock","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2019.06.004_bb0330","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1620\/tjem.240.323","article-title":"Effectiveness of medium-chain triglyceride oil therapy in two Japanese citrin-deficient siblings: evaluation using oral glucose tolerance tests","volume":"240","author":"Otsuka","year":"2016","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0335","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/lt.20131","article-title":"Feasibility of auxiliary partial orthotopic liver transplantation from living donors for patients with adult-onset type II citrullinemia","volume":"10","author":"Yazaki","year":"2004","journal-title":"Liver Transpl."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0340","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3918\/jsicm.1.37","article-title":"Hyperallimentation therapy produces a comatose stae in a patient with citrullinemia","volume":"1","author":"Tamakawa","year":"1994","journal-title":"J. Jpn. Soc. Intensive Care Med."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0345","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2169\/internalmedicine.44.188","article-title":"Risk of worsened encephalopathy after intravenous glycerol therapy in patients with adult-onset type II citrullinemia (CTLN2)","volume":"44","author":"Yazaki","year":"2005","journal-title":"Intern. Med."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0350","first-page":"CS13","article-title":"A case of adult-onset type II citrullinemia - deterioration of clinical course after infusion of hyperosmotic and high sugar solutions","volume":"12","author":"Takahashi","year":"2006","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.ymgme.2019.06.004_bb0355","first-page":"865","article-title":"Type II citrullinemia triggered by acetaminophen","volume":"45","author":"Shiohama","year":"1993","journal-title":"No To Shinkei."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719219303270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719219303270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:22:42Z","timestamp":1761088962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719219303270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1096719219303270"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2019.06.004","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current treatment for citrin deficiency during NICCD and adaptation\/compensation stages: Strategy to prevent CTLN2","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2019.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}